| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-105 |
Sentence |
denotes |
A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement. |
| T2 |
106-117 |
Sentence |
denotes |
OBJECTIVES: |
| T3 |
118-336 |
Sentence |
denotes |
This study was designed to assess whether the reinforcement of the antioxidant system, through n-3 fatty acids plus antioxidant vitamin supplementation, could reduce the incidence of post-operative atrial fibrillation. |
| T4 |
337-348 |
Sentence |
denotes |
BACKGROUND: |
| T5 |
349-422 |
Sentence |
denotes |
Therapy to prevent post-operative atrial fibrillation remains suboptimal. |
| T6 |
423-567 |
Sentence |
denotes |
Although oxidative stress plays a key role in the pathogenesis of this arrhythmia, antioxidant reinforcement has produced controversial results. |
| T7 |
568-576 |
Sentence |
denotes |
METHODS: |
| T8 |
577-836 |
Sentence |
denotes |
A total of 203 patients scheduled for on-pump cardiac surgery were randomized to placebo or supplementation with n-3 polyunsaturated fatty acids (2 g/day) (eicosapentaenoic acid:docosahexaenoic acid ratio 1:2), vitamin C (1 g/day), and vitamin E (400 IU/day). |
| T9 |
837-914 |
Sentence |
denotes |
The primary outcome was the occurrence of post-operative atrial fibrillation. |
| T10 |
915-999 |
Sentence |
denotes |
Secondary outcomes were the biomarkers related to oxidative stress and inflammation. |
| T11 |
1000-1008 |
Sentence |
denotes |
RESULTS: |
| T12 |
1009-1173 |
Sentence |
denotes |
Post-operative atrial fibrillation occurred in 10 of 103 patients (9.7%) in the supplemented group versus 32 of 100 patients (32%) in the placebo group (p < 0.001). |
| T13 |
1174-1358 |
Sentence |
denotes |
Early after surgery, placebo patients presented with increased levels of biomarkers of inflammation and oxidative stress, which were markedly attenuated by antioxidant supplementation. |
| T14 |
1359-1561 |
Sentence |
denotes |
The activity of catalase, superoxide dismutase, and glutathione peroxidase in atrial tissue of the supplemented patients was 24.0%, 17.1%, and 19.7% higher than the respective placebo values (p < 0.05). |
| T15 |
1562-1771 |
Sentence |
denotes |
The atrial tissue of patients who developed atrial fibrillation showed NADPH oxidase p47-phox subunit protein and mRNA expression 38.4% and 35.7% higher, respectively, than patients in sinus rhythm (p < 0.05). |
| T16 |
1772-1784 |
Sentence |
denotes |
CONCLUSIONS: |
| T17 |
1785-2107 |
Sentence |
denotes |
This safe, well-tolerated, and low-cost regimen, consisting of n-3 polyunsaturated fatty acids plus vitamins C and E supplementation, favorably affected post-operative atrial fibrillation, increased antioxidant potential, and attenuated oxidative stress and inflammation. (Prevention of Post-Operative Atrial Fibrillation: |
| T18 |
2108-2249 |
Sentence |
denotes |
Pathophysiological Characterization of a Pharmacological Intervention Based on a Novel Model of Nonhypoxic Pre-Conditioning; ISRCTN45347268). |
| T1 |
0-105 |
Sentence |
denotes |
A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement. |
| T2 |
106-117 |
Sentence |
denotes |
OBJECTIVES: |
| T3 |
118-336 |
Sentence |
denotes |
This study was designed to assess whether the reinforcement of the antioxidant system, through n-3 fatty acids plus antioxidant vitamin supplementation, could reduce the incidence of post-operative atrial fibrillation. |
| T4 |
337-348 |
Sentence |
denotes |
BACKGROUND: |
| T5 |
349-422 |
Sentence |
denotes |
Therapy to prevent post-operative atrial fibrillation remains suboptimal. |
| T6 |
423-567 |
Sentence |
denotes |
Although oxidative stress plays a key role in the pathogenesis of this arrhythmia, antioxidant reinforcement has produced controversial results. |
| T7 |
568-576 |
Sentence |
denotes |
METHODS: |
| T8 |
577-836 |
Sentence |
denotes |
A total of 203 patients scheduled for on-pump cardiac surgery were randomized to placebo or supplementation with n-3 polyunsaturated fatty acids (2 g/day) (eicosapentaenoic acid:docosahexaenoic acid ratio 1:2), vitamin C (1 g/day), and vitamin E (400 IU/day). |
| T9 |
837-914 |
Sentence |
denotes |
The primary outcome was the occurrence of post-operative atrial fibrillation. |
| T10 |
915-999 |
Sentence |
denotes |
Secondary outcomes were the biomarkers related to oxidative stress and inflammation. |
| T11 |
1000-1008 |
Sentence |
denotes |
RESULTS: |
| T12 |
1009-1173 |
Sentence |
denotes |
Post-operative atrial fibrillation occurred in 10 of 103 patients (9.7%) in the supplemented group versus 32 of 100 patients (32%) in the placebo group (p < 0.001). |
| T13 |
1174-1358 |
Sentence |
denotes |
Early after surgery, placebo patients presented with increased levels of biomarkers of inflammation and oxidative stress, which were markedly attenuated by antioxidant supplementation. |
| T14 |
1359-1561 |
Sentence |
denotes |
The activity of catalase, superoxide dismutase, and glutathione peroxidase in atrial tissue of the supplemented patients was 24.0%, 17.1%, and 19.7% higher than the respective placebo values (p < 0.05). |
| T15 |
1562-1771 |
Sentence |
denotes |
The atrial tissue of patients who developed atrial fibrillation showed NADPH oxidase p47-phox subunit protein and mRNA expression 38.4% and 35.7% higher, respectively, than patients in sinus rhythm (p < 0.05). |
| T16 |
1772-1784 |
Sentence |
denotes |
CONCLUSIONS: |
| T17 |
1785-2107 |
Sentence |
denotes |
This safe, well-tolerated, and low-cost regimen, consisting of n-3 polyunsaturated fatty acids plus vitamins C and E supplementation, favorably affected post-operative atrial fibrillation, increased antioxidant potential, and attenuated oxidative stress and inflammation. (Prevention of Post-Operative Atrial Fibrillation: |
| T18 |
2108-2249 |
Sentence |
denotes |
Pathophysiological Characterization of a Pharmacological Intervention Based on a Novel Model of Nonhypoxic Pre-Conditioning; ISRCTN45347268). |